Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Product Unit Size | Cost | Quantity | Stock |
---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Purity | ≥95% |
---|---|
Formula | C18H25N5O5S |
Formula Wt. | 423.4 |
Synonym | MGP-pNa |
Solubility | Soluble in water. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Mycotoxin produced by Penicillum and Aspergillu...
BRD binding agent, CDK1/2/5/9 inhibitor.
Endogenous peptide hormone, counteracts insulin...
β2-adrenergic agonist, BChE inhibitor.
Pyrrolidone; NMDA and mGluR5 agonist, N-type an...
Aromatase inhibitor.
Statin, naturally produced by mushrooms; HMG-Co...
Recombinant BNP, cardiomodulatory peptide; NPR-...
Electron carrier used to study dehydrogenase el...
Non-nitrogen bisphosphonate; mitochondrial ATP/...
Found in Astragalus membranaceus.
NMDA NR1/NR2B antagonist.
α3β2, α3β4, α4β2 nAChR antagonist, indire...
p110δ PI3K inhibitor.
H+/K+ ATPase inhibitor.
Endogenous peptide hormone, involved in secreti...
Endogenous opioid peptide; μOr agonist.
Statin; HMG-CoA reductase inhibitor, potential ...
5-HT1A and σ1/2 agonist, 5-HT2A/2C/6/7, D1-4, ...
Nucleoside (thymidine) analog; DNA chain termin...